Finance

Lists
ABT:NYSE
Abbott Laboratories
US$100,75
+0,18%
(+0,18) 1D
US$100,18
-0,56% (-0,57)
After hours
Closed: 23 ກ.ລ., 16 ໂມງ 4 ນາທີ 11 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ABT...
Open
US$101,23
High
US$101,90
Low
US$100,07
Mkt. cap
໑໗໕,໔໙ ຕື້
Avg. vol.
໑໔,໓໐ ລ້ານ
Volume
໙,໙໕ ລ້ານ
Dividend
໒,໕໐%
Quarterly dividend
US$0,63
Ex-dividend date
15 ກ.ລ. 2026
P/E ratio
໓໒,໔໓
52-wk high
US$137,49
52-wk low
US$81,97
EPS
US$3,11
Beta
໐,໖໑
Shares outstanding
໑,໗໔ ຕື້
No. of employees
໑໑໕ ພັນ
Open
US$101,23
High
US$101,90
Low
US$100,07
Mkt. cap
໑໗໕,໔໙ ຕື້
Avg. vol.
໑໔,໓໐ ລ້ານ
Volume
໙,໙໕ ລ້ານ
Dividend
໒,໕໐%
Quarterly dividend
US$0,63
Ex-dividend date
15 ກ.ລ. 2026
P/E ratio
໓໒,໔໓
52-wk high
US$137,49
52-wk low
US$81,97
EPS
US$3,11
Beta
໐,໖໑
Shares outstanding
໑,໗໔ ຕື້
No. of employees
໑໑໕ ພັນ
News stories
From sources across the web
Simply Wall Street
Simply Wall Street
·
1 ຊົ່ວໂມງກ່ອນ
Abbott Stock And 2 Dividend Ideas For Retirement Income
TradingView
TradingView
·
3 ຊົ່ວໂມງກ່ອນ
ISRG vs. ABT: Which MedTech Giant Is the Smarter Investment Now?
Yahoo! Finance Canada
Yahoo! Finance Canada
·
20 ຊົ່ວໂມງກ່ອນ
Abbott Laboratories (ABT) Earnings Drew Fresh Attention, Is It Still Below Fair Value?
MSN
MSN
·
1 ມື້ກ່ອນ
This dividend king could be one of the safest stocks to own right now
Profile
Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company founded in Chicago with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices. Abbott operates in over 160 countries and sources from at least 62 suppliers worldwide. Abbott's products include Pedialyte, Similac, BinaxNOW, Ensure, Glucerna, ZonePerfect, FreeStyle Libre, i-STAT and MitraClip. The company is ranked 107th on the Fortune 500 and 144th on the Forbes Global 2000. Wikipedia
About Abbott Laboratories
CEORobert B. Ford
Employees115 ພັນ
Founded1888
Headquartersຊິຄາໂກ, ອິລິນອຍ, ສະຫະລັດ
SectorMedical device
Websiteabbott.com
Analyst ratings
Based on 14 analysts giving stock ratings to ABT in the past 3 months
Strong buy
Buy
14
Hold
0
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for ABT in the last 3 months.
Highest
Current US$100,75
US$135,00 (+34,00%)
Average
US$119,75 (+18,86%)
Lowest
US$112,00 (+11,17%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
Jefferies
Buy
Reiterated
US$135,00
+34%
07/17/2026
Adam Maeder
Piper Sandler
Buy
Reiterated
US$118,00
+17,1%
07/17/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
US$130,00
+29%
07/16/2026
Robbie Marcus
J.P. Morgan
Buy
Maintained
US$120,00
+19,1%
07/17/2026
Joanne Wuensch
Citi
Buy
Maintained
US$112,00
+11,2%
07/17/2026
Marie Thibault
BTIG
Buy
Maintained
US$134,00
+33%
07/16/2026
Larry Biegelsen
Wells Fargo
Buy
Maintained
US$112,00
+11,2%
07/17/2026
Jayson Bedford
Raymond James
Buy
Maintained
-
-
07/17/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
07/16/2026
Josh Jennings
TD Cowen
Buy
Reiterated
US$115,00
+14,1%
07/16/2026
Travis Steed
Bank of America Securities
Buy
Maintained
US$115,00
+14,1%
07/16/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
US$112,00
+11,2%
07/06/2026
David Rescott
Robert W. Baird
Buy
Initiated
US$121,00
+20,1%
06/30/2026
Unknown Analyst
J.P. Morgan
Buy
Maintained
US$110,00
+9,2%
06/29/2026
David Roman
Goldman Sachs
Buy
Maintained
US$113,00
+12,2%
05/31/2026
Narumi Nakagiri
Daiwa
Hold
Downgraded
US$92,00
-8,7%
04/21/2026
Danielle Antalffy
UBS
Buy
Reiterated
US$135,00
+34%
04/20/2026
Anthony Petrone
Mizuho Securities
Hold
Maintained
US$115,00
+14,1%
04/20/2026
Matt Miksic
Barclays
Buy
Reiterated
US$143,00
+41,9%
04/20/2026
Matthew Taylor
Jefferies
Buy
Reiterated
US$135,00
+34%
04/17/2026
Suraj Kalia
Oppenheimer
Buy
Maintained
US$115,00
+14,1%
04/17/2026
Bruce Jackson
Benchmark Co.
Buy
Maintained
US$120,00
+19,1%
04/17/2026
Rick Wise
Stifel Nicolaus
Buy
Reiterated
US$120,00
+19,1%
04/17/2026
Michael Polark
Wolfe Research
Hold
Maintained
-
-
04/16/2026
Unknown Analyst
Goldman Sachs
Buy
Reiterated
US$121,00
+20,1%
04/09/2026
Unknown Analyst
Erste Group
Hold
Maintained
-
-
04/01/2026
Last report
16 ກ.ລ. 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
US$1,31 / US$1,28
+2,61%beat
Revenue / Est. (USD)
໑໒,໕໙ ຕື້ / ໑໒,໕໒ ຕື້
+0,61%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
11,37 ຕື້
11,46 ຕື້
11,16 ຕື້
12,59 ຕື້
Cost of goods sold
5,08 ຕື້
4,91 ຕື້
4,89 ຕື້
5,29 ຕື້
Cost of revenue
5,08 ຕື້
4,91 ຕື້
4,89 ຕື້
5,29 ຕື້
Research and development expenses
766,00 ລ້ານ
720,00 ລ້ານ
767,00 ລ້ານ
882,00 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,90 ຕື້
2,93 ຕື້
3,58 ຕື້
3,98 ຕື້
Operating expense
4,09 ຕື້
4,07 ຕື້
4,77 ຕື້
5,52 ຕື້
Total operating expenses
9,16 ຕື້
8,98 ຕື້
9,66 ຕື້
10,81 ຕື້
Operating income
2,20 ຕື້
2,48 ຕື້
1,50 ຕື້
1,78 ຕື້
Other non operating income
2,00 ລ້ານ
-15,00 ລ້ານ
-
134,00 ລ້ານ
EBT including unusual items
2,18 ຕື້
2,36 ຕື້
1,45 ຕື້
1,52 ຕື້
EBT excluding unusual items
2,18 ຕື້
2,44 ຕື້
1,45 ຕື້
1,61 ຕື້
Income tax expense
536,00 ລ້ານ
582,00 ລ້ານ
372,00 ລ້ານ
596,00 ລ້ານ
Effective tax rate
24,59%
24,68%
25,67%
39,11%
Other operating expenses
-
-
-
-
Net income
1,64 ຕື້
1,78 ຕື້
1,08 ຕື້
928,00 ລ້ານ
Net profit margin
14,46%
15,50%
9,65%
7,37%
Earnings per share
1,30
1,50
1,15
1,31
Interest and investment income
77,00 ລ້ານ
78,00 ລ້ານ
106,00 ລ້ານ
-
Interest expense
-121,00 ລ້ານ
-120,00 ລ້ານ
-174,00 ລ້ານ
-299,00 ລ້ານ
Net interest expenses
-44,00 ລ້ານ
-42,00 ລ້ານ
-68,00 ລ້ານ
-299,00 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
3,00 ຕື້
3,27 ຕື້
2,31 ຕື້
2,58 ຕື້
Gain or loss from assets sale
-
65,00 ລ້ານ
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer